Frontiers in Oncology · 2023 · 12 citations · 20 references
MedicineHematologyOncologyInflammationTumor ImmunologyTumor ProgressionBiliary Tract CancerCancer Survival AnalysisImmuno-oncology BiomarkersPrognostic AssessmentTumor ImmunopathologyDiagnostic Cutoff ValuesNeutrophil-to-lymphocyte RatioPerihilar Cholangiocarcinoma SurgeryPlatelet-to-lymphocyte RatioPrognostic Marker AssessmentRecurrence-free SurvivalSurvival RatesTumor-associated Inflammation
Background & Aims: Tumor-associated chronic inflammation has been determined to play a crucial role in tumor progression, angiogenesis and immunosuppression. The objective of this study was to assess the prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in perihilar cholangiocarcinoma (pCCA) patients following curative resection. Methods: Consecutive pCCA patients following curative resection at 3 Chinese hospitals between 2014 and 2018 were included. The NLR was defined as the ratio of neutrophil count to lymphocyte count. PLR was defined as the ratio of platelet count to lymphocyte count. The optimal cutoff values of preoperative NLR and PLR were determined according to receiver operating characteristic (ROC) curves for the prediction of 1-year overall survival (OS), and all patients were divided into high- and low-risk groups. Kaplan-Meier curves and Cox regression models were used to investigate the relationship between values of NLR and PLR and values of OS and recurrence-free survival (RFS) in pCCA patients. The usefulness of NLR and PLR in predicting OS and RFS was evaluated by time-dependent ROC curves. Results: A total of 333 patients were included. According to the ROC curve for the prediction of 1-year OS, the optimal cutoff values of preoperative NLR and PLR were 1.68 and 113.1, respectively, and all patients were divided into high- and low-risk groups. The 5-year survival rates in the low-NLR (<1.68) and low-PLR groups (<113.1) were 30.1% and 29.4%, respectively, which were significantly higher than the rates of 14.9% and 3.3% in the high-NLR group (≥1.68) and high-PLR group (≥113.1), respectively. In multivariate analysis, high NLR and high PLR were independently associated with poor OS and RFS for pCCA patients. The time-dependent ROC curve revealed that both NLR and PLR were ideally useful in predicting OS and RFS for pCCA patients. Conclusions: This study found that both NLR and PLR could be used to effectively predict long-term survival in patients with pCCA who underwent curative resection.
20
Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao, Lei Wu, Guifang Yan et al. · Signal Transduction and Targeted Therapy · 2021 · 2.7K citations · Full text
Life Sciences, Immunology, Oncology +17
Lysis of tumor cells by natural killer cells in mice is impeded by platelets.
Bernhard Nieswandt, Michael Häfner, Bernd Echtenacher et al. · PubMed · 1999 · 838 citations
Life Sciences, Immunology, Oncology +13
Management Strategies in Resection for Hilar Cholangiocarcinoma
Henri Bismuth, Richard Nakache, Tom Diamond · Annals of Surgery · 1992 · 803 citations